Predicting Preclinical Cognitive Decline Using Plasma P-tau217 and <i>APOE</i> Genotype in 8,582 Individuals From Different Ethnic Groups
Yuexuan Xu(Nankai University), Richard Mayeux(Columbia University), Tamil Iniyan Gunasekaran(Chosun University), Danurys Sanchez(Columbia University Irving Medical Center), Jennifer J. Manly(Alzheimer’s Disease Neuroimaging Initiative), Angel Piriz(Columbia University), Rafael Lantigua, Ramiro Eduardo Rea Reyes(University of Wisconsin–Madison), Matthew J. Maenner(NewYork–Presbyterian Hospital), Adam Brickman(NewYork–Presbyterian Hospital), Sanjay Asthana(University of Wisconsin–Madison), Sid O'Bryant(University of North Texas), Lawrence Honig(NewYork–Presbyterian Hospital), Badri N Vardarajan(Columbia University), Yian Y Gu(NewYork–Presbyterian Hospital), David A Bennett(Rush University Medical Center), Sterling C. Johnson(University of Wisconsin–Madison), Melissa Petersen(University of North Texas), Rachael Wilson(University of Wisconsin–Madison), Alzheimer’s Disease Neuroimaging Initiative, Martin Medrano(Pontificia Universidad Católica Madre y Maestra), Dolly Reyes-Dumeyer(Columbia University), Diones Rivera Mejía(Instituto Tecnológico de Santo Domingo)
Cited by 0
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Epidemiology of Alzheimer Disease
|Cold Spring Harbor Perspectives in Medicine|2012|1.1k
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network
|Annals of Neurology|2016|553
Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
|New England Journal of Medicine|1998|552